Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2025
  • November
  • Page 35
nursing-students’-environmental-health-literacy-explored
Posted inBiotechnology

Nursing Students’ Environmental Health Literacy Explored

November 24, 2025
In the modern landscape of healthcare, the significance of environmental health literacy among nursing students cannot be overstated. As future…
Read More
versant’s-dayra-dawns-with-$50m-biogen-pact,-oral-macrocyclic-peptide-mission
Posted inBiotechnology

Versant’s Dayra dawns with $50M Biogen pact, oral macrocyclic peptide mission

November 24, 2025
VC Versant Ventures is unveiling Dayra Therapeutics, a new biotech working on oral macrocyclic peptide drugs—a mission that has already…
Read More
j&j’s-$5b-alzheimer’s-hope-fades-as-anti-tau-antibody-posdinemab-flops-in-phase-2
Posted inBiotechnology

J&J’s $5B Alzheimer’s hope fades as anti-tau antibody posdinemab flops in phase 2

November 24, 2025
Johnson & Johnson’s attempt to develop a $5 billion-a-year Alzheimer’s disease drug has been rocked by a phase 2 flop.…
Read More
solventum-to-buy-acera-surgical-for-up-to-$850m,-repurchase-$1b-in-stock
Posted inMedical Technology

Solventum to buy Acera Surgical for up to $850M, repurchase $1B in stock

November 24, 2025
Solventum, which spun out of 3M nearly two years ago, will shell out up to $850 million for wound care…
Read More
bayer’s-asundexian-cuts-stroke-risk-in-phase-3,-reviving-hopes-for-fxia-class
Posted inBiotechnology

Bayer’s asundexian cuts stroke risk in phase 3, reviving hopes for FXIa class

November 24, 2025
Bayer’s oral FXIa inhibitor asundexian has significantly reduced the risk of stroke in a phase 3 trial, giving a boost to…
Read More
stockwatch:-avadel-sparks-bidding-war;-agios-plummets-51%-on-phase-iii-data
Posted inGenetics

StockWatch: Avadel Sparks Bidding War; Agios Plummets 51% on Phase III Data

November 23, 2025
More than two weeks after Pfizer (NYSE: PFE) and Novo Nordisk (NASDAQ Copenhagen: NOVO-B) slugged it out for Metsera (NASDAQ:…
Read More
immune-cell-profiling-in-type-1-diabetes-identifies-changes-in-memory-t-cells-and-b-cells
Posted inGenetics

Immune Cell Profiling in Type 1 Diabetes Identifies Changes in Memory T Cells and B Cells

November 22, 2025
Scientists analyzing human and mouse pancreatic lymph nodes (PLNs) and spleens have identified a distinct subset of CD4 memory helper…
Read More
ginkgo-datapoints-launches-virtual-cell-initiative-for-ai-drug-discovery
Posted inGenetics

Ginkgo Datapoints Launches Virtual Cell Initiative for AI Drug Discovery

November 21, 2025
Credit: Jackie Niam / iStock / Getty Images Plus Ginkgo Bioworks has announced the launch of the Virtual Cell Pharmacology Initiative (VCPI)…
Read More
novartis-plans-to-build-flagship-manufacturing-hub-in-north-carolina
Posted inGenetics

Novartis Plans to Build Flagship Manufacturing Hub in North Carolina

November 21, 2025
Credit: Tom Werner/Getty Images Officials at Novartis report that the company plans to expand its operations in North Carolina, creating…
Read More
hiv-integrase-captured-by-cryo-em-in-two-structural-states
Posted inGenetics

HIV Integrase Captured by Cryo-EM in Two Structural States

November 21, 2025
On the left is integrase in its “intasome” structure of four identical four-part complexes (pink) that connect to create one…
Read More

Posts pagination

Previous page 1 … 33 34 35 36 37 … 93 Next page

Privacy Policy    Terms

Scroll to Top